首页> 外文OA文献 >A3-03: Pemetrexed for the treatment of advanced non-small cell lung cancer (NSCLC): Results from a randomized phase III dose finding trial in patients who progressed following platinum-containing chemotherapy

【2h】

A3-03: Pemetrexed for the treatment of advanced non-small cell lung cancer (NSCLC): Results from a randomized phase III dose finding trial in patients who progressed following platinum-containing chemotherapy

机译：A3-03：培美曲塞治疗晚期非小细胞肺癌（NSCLC）：一项随机的III期剂量寻找试验的结果，该试验针对含铂化疗后的患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Cullen Michael H.; Zatloukal Petr; Sorenson Sverre; Novello Silvia; Fischer Juergen R.; Anil Abraham Joy; Zereu Manuela; Peterson Patrick; Visseren-Grul Carla; Iscoe Neill;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. [J] . Fossella FV, DeVore R, Kerr RN, Journal of Clinical Oncology . 2000,第12期

机译：多西他赛与长春瑞滨或异环磷酰胺在之前接受过含铂化疗方案治疗的晚期非小细胞肺癌患者中的随机III期试验。 TAX 320非小细胞肺癌研究组。
2. A Randomized Phase III Trial of Single-Agent Pemetrexed (P) Versus Carbopiatin and. Pemetrexed (CP) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) and Performance Status (PS) of 2 [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla11期

机译：单药培美曲塞（P）与卡波比汀和卡比汀的随机III期试验。培美曲塞（CP）在晚期非小细胞肺癌（NSCLC）和性能状态（PS）为2的患者中
3. A phase (1 randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platthum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer [J] . Hui Yu, Jian Zhang, Xianghua Wu, Cancer biology & therapy . 2014,第7期

机译：一项阶段性（1项随机试验，评估吉非替尼在非选择的晚期非鳞状非小细胞肺癌患者中单独接受培美曲塞/铂化疗或培美曲塞/铂化疗
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer [O] . Hui Yu, Jian Zhang, Xianghua Wu, 2014

机译：II期随机试验评估吉非替尼在未选出的晚期非鳞状非小细胞肺癌患者中单独接受培美曲塞/铂化疗或培美曲塞/铂化疗
7. P2-328: Is pemetrexed more effective in adenocarcinoma and large cell lung cancer than in squamous cell carcinoma? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC) [O] . Peterson Patrick, Park Keunchil, Fossella Frank, 2007

机译：P2-328：培美曲塞在腺癌和大细胞肺癌中是否比鳞状细胞癌更有效？培美曲塞与多西他赛在先前治疗的晚期非小细胞肺癌（NSCLC）患者中进行的III期临床试验的回顾性分析

A3-03: Pemetrexed for the treatment of advanced non-small cell lung cancer (NSCLC): Results from a randomized phase III dose finding trial in patients who progressed following platinum-containing chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅